Biotech Acquisition Company
Financial ratios & Valuation

Historical Multiples (2020 – 2021)

2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
N/A-23.26N/AN/A
Price/Sales ratio
N/AN/AN/AN/A
Price/Book Value ratio
13.94K-10.41MN/AN/A
Price/Cash Flow ratio
N/A-193.07N/AN/A
Price/Free Cash Flow ratio
N/A-193.07N/AN/A
Price/Earnings Growth ratio
N/AN/AN/AN/A
Dividend Yield
N/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/A
Effective Tax Rate
N/A-77.12%N/AN/A
Return on Assets
N/A-5279159.42%4.74%4.74%
Return On Equity
N/A44751966.60%11.40%44751966.60%
Return on Capital Employed
N/A-682659.98%-1.64%-1.64%
Liquidity Ratios
Current Ratio
N/AN/A0.02N/A
Quick Ratio
N/A0.950.000.95
Cash ratio
N/A0.290.000.29
Days of Sales Outstanding
N/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.77N/A0.05N/A
Debt Equity Ratio
3.47N/A0.06N/A
Long-term Debt to Capitalization
N/AN/AN/AN/A
Total Debt to Capitalization
0.77N/AN/AN/A
Interest Coverage Ratio
N/AN/A-3.68N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/A
Company Equity Multiplier
4.47-8.471.061.06
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
N/A111
Cash Flow Coverage Ratio
N/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/A-1.26N/A
Dividend Payout Ratio
N/AN/AN/AN/A